RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
BioVendor MDx, Karasek 1, Brno, Czech Republic.
Sci Rep. 2024 Aug 6;14(1):18163. doi: 10.1038/s41598-024-68953-z.
Intrapartum antibiotic prophylaxis (IAP) is commonly used during C-section delivery and in Group B Streptococcus-positive women before vaginal delivery. Here, we primarily aimed to investigate the effect of IAP on the neonatal oral and fecal bacteriomes in the first week of life. In this preliminary study, maternal and neonatal oral swabs and neonatal fecal (meconium and transitional stool) swabs were selected from a pool of samples from healthy mother-neonate pairs participating in the pilot phase of CELSPAC: TNG during their hospital stay. The DNA was extracted and bacteriome profiles were determined by 16S rRNA amplicon sequencing (Illumina). In the final dataset, 33 mother-neonate pairs were exposed to antibiotics during C-section or vaginal delivery (cases; +IAP) and the vaginal delivery without IAP (controls, -IAP) took place in 33 mother-neonate pairs. Differences in alpha diversity (Shannon index, p=0.01) and bacterial composition (PERMANOVA, p<0.05) between the +IAP and -IAP groups were detected only in neonatal oral samples collected ≤48 h after birth. No significant differences between meconium bacteriomes of the +IAP and -IAP groups were observed (p>0.05). However, the IAP was associated with decreased alpha diversity (number of amplicon sequence variants, p<0.001), decreased relative abundances of the genera Bacteroides and Bifidobacterium, and increased relative abundances of genera Enterococcus and Rothia (q<0.01 for all of them) in transitional stool samples. The findings of this study suggest that exposure to IAP may significantly influence the early development of the neonatal oral and gut microbiomes. IAP affected the neonatal oral bacteriome in the first two days after birth as well as the neonatal fecal bacteriome in transitional stool samples. In addition, it highlights the necessity for further investigation into the potential long-term health impacts on children.
剖宫产术中及 B 族链球菌阳性孕妇阴道分娩前常使用宫腔内抗生素预防(IAP)。在这里,我们主要旨在研究 IAP 对新生儿出生后第一周口腔和粪便细菌组的影响。在这项初步研究中,从参与 CELSPAC:TNG 试点阶段的健康母婴对中选择了一组样本,包括母亲和新生儿口腔拭子以及新生儿粪便(胎粪和过渡性粪便)拭子。提取 DNA 并通过 16S rRNA 扩增子测序(Illumina)确定细菌组谱。在最终数据集,33 对母婴在剖宫产或阴道分娩期间接触抗生素(病例;+IAP),33 对母婴阴道分娩无 IAP(对照组,-IAP)。仅在出生后≤48 小时采集的新生儿口腔样本中,+IAP 和-IAP 组之间的 alpha 多样性(Shannon 指数,p=0.01)和细菌组成(PERMANOVA,p<0.05)存在差异。+IAP 和-IAP 组胎粪细菌组之间未观察到显著差异(p>0.05)。然而,IAP 与 alpha 多样性降低(扩增子序列变异数,p<0.001)、Bacteroides 和 Bifidobacterium 属相对丰度降低以及 Enterococcus 和 Rothia 属相对丰度增加有关(所有属 q<0.01)在过渡性粪便样本中。本研究的结果表明,暴露于 IAP 可能会显著影响新生儿口腔和肠道微生物组的早期发育。IAP 影响出生后前两天新生儿口腔细菌组和过渡性粪便样本中的新生儿粪便细菌组。此外,它强调了需要进一步研究对儿童潜在的长期健康影响。